Neuroplant Aktiv

St. John's Wort, the active ingredient in Neuroplant Aktiv, is a herbal antidepressant presented as a dry extract for oral use. It is used to support mood in adults with mild to moderate depression and related mood disorders.

GNH USA supplies Neuroplant Aktiv as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Neuroplant Aktiv, a herbal antidepressant, acts on neurotransmitter pathways associated with mood regulation. - Mild to moderate depression: helps improve mood and reduce depressive symptoms. - Mood disorders: may alleviate emotional instability and low mood. - Seasonal affective disorder: supports mood during periods of reduced daylight.

St. John's Wort may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Gastrointestinal upset: nausea, stomach discomfort. - Skin reactions: rash, photosensitivity. - Fatigue or dizziness: transient feelings of tiredness. - Headache: mild to moderate intensity. - Insomnia: difficulty falling or staying asleep.

Serious or Rare Side Effects: - Serotonin syndrome: risk when combined with other serotonergic agents. - Severe allergic reaction: anaphylaxis or angioedema. - Liver enzyme elevation: potential hepatic involvement. - Mood worsening: rare exacerbation of depressive symptoms. - Bleeding tendency: increased risk of hemorrhage, especially with anticoagulants.

When considering Neuroplant Aktiv, several safety measures should be observed. - Contraindication: avoid use in patients with known hypersensitivity to Hypericum perforatum. - Pregnancy and lactation: safety not established; consult a healthcare professional before use. - Drug interactions: review concomitant medications for serotonergic activity. - Monitoring: assess mood changes regularly, especially during therapy initiation. - Storage: Store below 25°C: keep in the original container, protect from moisture and direct sunlight.

St. John's Wort interacts with several drug classes, requiring careful management.

Major Interactions (Avoid): - SSRIs, SNRIs, MAO inhibitors: risk of serotonin syndrome. - Warfarin and other anticoagulants: may reduce anticoagulant effect and increase bleeding risk. - Oral contraceptives: can lower hormonal efficacy, leading to unintended pregnancy.

Moderate Interactions (Monitor Closely): - Antiepileptic drugs (e.g., carbamazepine, phenytoin): may reduce plasma levels. - Immunosuppressants (e.g., cyclosporine): potential decrease in drug exposure. - Statins metabolized by CYP3A4: possible reduction in lipid‑lowering effect.